scholarly article | Q13442814 |
P50 | author | Thomas B Huffaker | Q106584674 |
June L Round | Q87779262 | ||
P2093 | author name string | Ryan M O'Connell | |
W Zac Stephens | |||
Allie H Grossmann | |||
Matthew A Williams | |||
H Atakan Ekiz | |||
P2860 | cites work | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 |
Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein | Q24641913 | ||
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder | Q24649158 | ||
CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control | Q24676449 | ||
MicroRNA-155 is induced during the macrophage inflammatory response | Q24683841 | ||
MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
Regulation of microRNA biogenesis | Q28243976 | ||
MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease | Q28596130 | ||
limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data | Q31034005 | ||
TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages | Q31165459 | ||
MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene | Q34107532 | ||
Regulation of the MIR155 host gene in physiological and pathological processes | Q34318174 | ||
Genomic Classification of Cutaneous Melanoma | Q34670776 | ||
miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines. | Q34985536 | ||
Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer | Q35871752 | ||
Exosome-delivered microRNAs modulate the inflammatory response to endotoxin | Q36018633 | ||
Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα. | Q36905043 | ||
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer | Q37059796 | ||
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq | Q37094024 | ||
Macrophage polarization in tumour progression | Q37158140 | ||
MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression | Q37172065 | ||
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy | Q37193493 | ||
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer | Q37210788 | ||
Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. | Q37586065 | ||
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity | Q37734258 | ||
Control of immune response by amino acid metabolism | Q37773432 | ||
Tumor-infiltrating lymphocytes and their significance in melanoma prognosis | Q38164610 | ||
Identifying cell populations with scRNASeq. | Q38676765 | ||
Revisit linear regression-based deconvolution methods for tumor gene expression data | Q38692499 | ||
MYC regulates the antitumor immune response through CD47 and PD-L1 | Q38787131 | ||
Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression | Q39087629 | ||
MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. | Q39176725 | ||
Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity | Q39234961 | ||
Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo. | Q39302905 | ||
microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis | Q39377895 | ||
MicroRNA-155 targets the SKI gene in human melanoma cell lines | Q39564201 | ||
The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. | Q41052928 | ||
Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers. | Q42380545 | ||
miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation | Q42631760 | ||
A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. | Q43787598 | ||
Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment | Q43881058 | ||
A description of the Molecular Signatures Database (MSigDB) Web site | Q46317320 | ||
Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade. | Q47799445 | ||
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. | Q47883923 | ||
A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. | Q52126962 | ||
Understanding the tumor immune microenvironment (TIME) for effective therapy. | Q52311744 | ||
ImmPort, toward repurposing of open access immunological assay data for translational and clinical research. | Q52683341 | ||
The Immune Landscape of Cancer. | Q52720878 | ||
Quantifying tumor-infiltrating immune cells from transcriptomics data. | Q52726457 | ||
Mutation load estimation model as a predictor of the response to cancer immunotherapy. | Q55261882 | ||
Integrating single-cell transcriptomic data across different conditions, technologies, and species | Q88243551 | ||
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment | Q89367617 | ||
The effect of cellular context on miR-155-mediated gene regulation in four major immune cell types | Q91495449 | ||
P4510 | describes a project that uses | limma | Q112236343 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
Expression profiling | Q60147249 | ||
single cell transcriptomics | Q105406038 | ||
P577 | publication date | 2019-03-21 | |
P1433 | published in | JCI insight | Q27727187 |
P1476 | title | MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers | |
P478 | volume | 4 |
Q90044590 | Mitochondrial Pyruvate Carrier 1 Promotes Peripheral T Cell Homeostasis through Metabolic Regulation of Thymic Development |
Q90243992 | T Cell-Expressed microRNA-155 Reduces Lifespan in a Mouse Model of Age-Related Chronic Inflammation |
Q98465623 | microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy |
Search more.